Gene Editing Experts Gather at Montgomery College to Discuss Transformative Potential of CRISPR on Genomic Medicine

Published on :

Gene Editing Experts Gather at Montgomery College to Discuss Transformative Potential of CRISPR on Genomic Medicine Montgomery College’s Bioscience Education Center (BEC) is the place to be, to see and to hear from some of the brightest life science minds in BioHealth Capital Region (BHCR).  Home to the region’s most important biotech workforce development and [….]

This Startup is on a Mission to Decentralize Cell and Gene Therapy Clinical Trials

Published on :

This Startup is on a Mission to Decentralize Cell and Gene Therapy Clinical Trials For the cell and gene therapy revolution to be fully realized, physicians, research scientists, biomanufacturing experts, advocacy groups, regulatory bodies like the Food & Drug Administration (FDA) and other key stakeholders have to “Think Different”, as Apple famously encouraged. The “vein-to-vein”, [….]

Biomanufacturing and Supply Chain Standardization Key to Success in Cell and Gene Therapy Industry Boom

Published on :

Biomanufacturing and Supply Chain Standardization Key to Success in Cell and Gene Therapy Industry Boom The Wild West. Like changing the engine of a car while driving down the highway. This was how several cell and gene therapy industry leaders characterized the field’s rapidly developing Biomanufacturing and supply chain environment at this year’s Maryland Tech [….]

First Car-T for an Autoimmune Disease Enters Clinic

Published on :

First Car-T for an Autoimmune Disease Enters Clinic Maryland-Based Cartesian Therapeutics Initiates CAR-T Clinical Trial in Myasthenia Gravis Gaithersburg, MD, November 5, 2019 – see full press release Founded in 2016 by a pair of MD/PhD scientists and serial life sciences entrepreneurs, Cartesian Therapeutics is out to rapidly translate discoveries into clinical trials, and trials into [….]

Emerging T Cell Therapy Company NexImmune Receives First IND Clearance for Phase 1/2 Trial in Acute Myeloid Leukemia / Myelodysplastic Syndrome

Published on :

Emerging T Cell Therapy Company NexImmune Receives First IND Clearance for Phase 1/2 Trial in Acute Myeloid Leukemia / Myelodysplastic Syndrome October 31, 2019 07:30 ET | Source: NexImmune, Inc. IND clearance enables commencement of clinical trial to evaluate NEXI-001 in AML/MDS patients with relapsed disease after allogeneic stem cell transplant IND clearance validates Company’s Artificial Immune Modulation [….]

For 20 Years This Company Has Helped to Shape the Field of Cell Therapy

Published on :

For 20 Years This Company Has Helped to Shape the Field of Cell Therapy  How MaxCyte Has Evolved to Become Leading Technology Provider for Cell Engineering and Leveraged Its Flow Electroporation® Technology and Know-How to Launch Its Own Robust CAR Pipeline  MaxCyte, located in Gaithersburg, Maryland, is a unique biotech company that is a key [….]